ABVC BioPharma, Inc. (ABVC) Reports 103% Asset Surge, Eyeing Phase III Trials for Depression Therapies
ABVC BioPharma, Inc. (NASDAQ:ABVC) tops our list for being one of the best penny stocks.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 41,706 | $92,796 | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.15 | 10,000 | $1,500.00 | 10,000 | 2010-05-11 | Filing | |
| $0.26 | 2,000 | $520.00 | 2,000 | 2010-03-22 | Filing | |
| $50,000.00 | 714,286 | $35,714,300,000.00 | 16,585,538 | 2009-11-13 | Filing | |
| $50,000.00 | 192,308 | $9,615,400,000.00 | 18,430,752 | 2009-08-31 | Filing | |
| $50,000.00 | 192,308 | $9,615,400,000.00 | 17,349,752 | 2009-08-31 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.00 | 4,000,000 | $4,000,000.00 | 10,637,500 | 2009-01-23 | Filing | |
| $1.00 | 4,000,000 | $4,000,000.00 | 10,637,500 | 2009-01-23 | Filing |